Compound Detail
CHEMBL344159
TOLVAPTAN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL344159 |
| Name | TOLVAPTAN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | GYHCTFXIZSNGJT-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
12
Targets
20
Activities
3
Assay Types
12
PK Parameters
20
Publications
7
Known Names
13
Indications
1
Mechanisms
Molecular Properties
448.9
MW (Da)
5.68
ALogP
3
HBA
2
HBD
69.6
PSA (Ų)
0.54
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2009 |
| Availability | Prescription |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vasopressin V2 receptor antagonist | ANTAGONIST | Vasopressin V2 receptor | ✓ | ✓ |
Indications
Cardiovascular Diseases Heart Failure Heart Failure Hyponatremia Inappropriate ADH Syndrome Polycystic Kidney Diseases Polycystic Kidney, Autosomal Dominant Dyspnea Edema, Cardiac Liver Cirrhosis Carcinoma Kidney Diseases Kidney Failure, Chronic
ATC Classification
C03XA01
tolvaptan
Level 1: CARDIOVASCULAR SYSTEM
Level 2: DIURETICS
Drug Warnings
Black Box Warning
hepatotoxicity
Activity Summary
Ki 11 meas. best 9.37
IC50 5 meas. best 8.35
EC50 4 meas. best 5.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vasopressin V2 receptor CHEMBL1790 | Ki | 9.37 | 8.94 | 0.4 | 4 |
| Unchecked CHEMBL612545 | Ki | 9.1 | 9.1 | 0.8 | 1 |
| Vasopressin V2 receptor CHEMBL1790 | IC50 | 8.35 | 8.15 | 4.5 | 2 |
| Vasopressin V1a receptor CHEMBL1889 | Ki | 7.5 | 7.015 | 32.0 | 2 |
| Mu-type opioid receptor CHEMBL233 | Ki | 6.39 | 6.39 | 410.0 | 1 |
| Vasopressin V1a receptor CHEMBL1889 | IC50 | 6.33 | 6.33 | 470.0 | 1 |
| Sigma intracellular receptor 2 CHEMBL4105907 | Ki | 5.99 | 5.99 | 1031.2 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 5.47 | 5.47 | 3400.0 | 1 |
| Glucose-dependent insulinotropic receptor CHEMBL5652 | EC50 | 5.4 | 5.4 | 4018.7 | 1 |
| Glucagon-like peptide 1 receptor CHEMBL1784 | EC50 | 5.33 | 5.33 | 4643.6 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 5.31 | 5.31 | 4856.2 | 1 |
| Free fatty acid receptor 4 CHEMBL5339 | EC50 | 5.29 | 5.29 | 5108.1 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 5.17 | 5.17 | 6687.3 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 5.0 | 5.0 | 9990.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 4262.33 | ng.hr.mL-1 | Homo sapiens |
| AUC | 824.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 961.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 967.0 | ng.hr.mL-1 | Mus musculus |
| CL | 164.0 | ml/min | Rattus norvegicus |
| Cmax | 877.6 | nM | Mus musculus |
| Cmax | 1951.22 | nM | Mus musculus |
| T1/2 | 0.3833 | hr | Rattus norvegicus |
| T1/2 | 4.1 | hr | Mus musculus |
| T1/2 | 2.23 | hr | Mus musculus |
| Tmax | 0.83 | hr | Mus musculus |
| Tmax | 0.33 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | HEK-293T | 10 |
| 35363466 | 10.1021/acs.jmedchem.2c00011 | Vasopressin V2 receptor | 9 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 9 |
| - | 10.6019/CHEMBL4689842 | U2OS | 8 |
| 35363466 | 10.1021/acs.jmedchem.2c00011 | ADMET | 7 |
| 38509003 | 10.1021/acs.jmedchem.4c00217 | ADMET | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| 35579344 | 10.1021/acs.jmedchem.2c00567 | ADMET | 5 |
| 35579344 | 10.1021/acs.jmedchem.2c00567 | Mus musculus | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
Data from ChEMBL 36 via Core Engine